Cite
Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
MLA
Zefarina Zulkafli, et al. “Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).” International Journal of Environmental Research and Public Health, vol. 18, July 2021, p. 7582. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0a49525e657f6e7a4ec2fc6888fab4a6&authtype=sso&custid=ns315887.
APA
Zefarina Zulkafli, Muhammad Farid Johan, Azlan Husin, Rosline Hassan, Asiful Islam, & Razan Hayati Zulkeflee. (2021). Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International Journal of Environmental Research and Public Health, 18, 7582.
Chicago
Zefarina Zulkafli, Muhammad Farid Johan, Azlan Husin, Rosline Hassan, Asiful Islam, and Razan Hayati Zulkeflee. 2021. “Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).” International Journal of Environmental Research and Public Health 18 (July): 7582. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0a49525e657f6e7a4ec2fc6888fab4a6&authtype=sso&custid=ns315887.